Attached files

file filename
EX-32.2 - CERTIFICATION - PEPTIDE TECHNOLOGIES, INC.exhibit32-2.htm
EX-31.2 - CERTIFICATION - PEPTIDE TECHNOLOGIES, INC.exhibit31-2.htm
EX-31.1 - CERTIFICATION - PEPTIDE TECHNOLOGIES, INC.exhibit31-1.htm
10-Q - QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2018 - PEPTIDE TECHNOLOGIES, INC.form10q.htm


Exhibit 32.1

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report of Peptide Technologies, Inc. (the ‘Company’) on Form 10-Q for the period ending June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the ‘Report’), I, Bruce Sellars, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
     
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Registrant Peptide Technologies, Inc.
   
Date : August 9, 2018 By: /s/ Bruce Sellars
  Bruce Sellars
  Chief Executive Officer (Principal Executive Officer)